000 | 01689 a2200505 4500 | ||
---|---|---|---|
005 | 20250513232127.0 | ||
264 | 0 | _c20010222 | |
008 | 200102s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZaugg, K | |
245 | 0 | 0 |
_aDifferential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412. _h[electronic resource] |
260 |
_bCancer research _cJan 2001 |
||
300 |
_a732-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDose-Response Relationship, Radiation |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aNeoplasms, Experimental _xdrug therapy |
650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
650 | 0 | 4 |
_aStaurosporine _xanalogs & derivatives |
650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aRocha, S | |
700 | 1 | _aResch, H | |
700 | 1 | _aHegyi, I | |
700 | 1 | _aOehler, C | |
700 | 1 | _aGlanzmann, C | |
700 | 1 | _aFabbro, D | |
700 | 1 | _aBodis, S | |
700 | 1 | _aPruschy, M | |
773 | 0 |
_tCancer research _gvol. 61 _gno. 2 _gp. 732-8 |
|
999 |
_c11150171 _d11150171 |